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Introduction: We investigated the main effects of shift work and sleep duration on cancer 
incidence, and effect modification of the shift work-cancer incidence association by sleep 
duration. Methods: Shift work and sleep duration were assessed among 21,804 participants from 
Alberta`s Tomorrow Project. Incident cases of breast, prostate, colorectal and lung cancers were 
identified through registry linkage. Results: Having worked ≥6 years of rotating shift work (HR 
= 1.59, 95 % CI = 1.07, 2.37; P = 0.02) and having ever worked night shifts were associated with 
an increased risk of lung cancer (HR=1.71, 95 % CI=1.18, 2.47; P = 0.01), whereas having ever 
worked night shifts was associated with a reduced risk of prostate cancer in the latency-adjusted 
model only (HR=0.70, 95 % CI=0.51, 0.98; P = 0.04). No associations were found between shift 
work or sleep duration on the risks of breast and colorectal cancers. Some evidence of effect 
modification by sleep duration for the rotating shift work-lung cancer incidence association was 
noted (P = 0.06), with stratified analyses revealing borderline increased risk of lung cancer in 
participants with ≥6 years of rotating shift work and <7 h of sleep/day (HR=2.27, 95 % CI=0.95, 
5.41; P = 0.07), and an increased risk of lung cancer in participants with 0.1−5.9 years of 
rotating shift work and >9 h of sleep/day (HR=2.99, 95 % CI=1.12, 7.97; P = 0.03). No 
additional evidence of effect modification by sleep duration for shift work and cancer incidence 
was noted. Discussion: A consistent association between shift work employment and lung 
cancer risk was noted in this Canadian sample. Furthermore, some evidence of effect 
modification of the rotating shift work-lung cancer risk association by sleep duration was noted. 
 






The length of shift work employment has been most consistently associated with prostate [1,2] 
and breast [3,4] cancers, whereas less consensus has been noted for colorectal [5,6] and lung 
[5,7] cancers. The relation between shift work length and cancer risk may also be modified by 
sleep duration. Two studies conducted in China have assessed the effects of night shift work and 
sleep duration on combined cancer risk [8] and breast cancer risk in females [9]. The first study 
noted an increased risk of combined cancers in males with at least two of the following risk 
factors: working night shifts ≥20 years, no daytime napping and a sleep duration ≥10 h/day [8]. 
The second study reported an increased risk of breast cancer in night shift workers who also 
reported shorter (<6 h/day) and longer (≥9 h/day) sleep durations. Given the variations in sleep 
habits and site-specific cancer incidence across geographical locations, additional studies in 
North American populations are needed to complement these initial findings from stratified 
analyses. 
 
This study aimed to investigate the associations between shift work in the form of years of 
rotating shift work or having ever (versus never) worked night shifts, as well as sleep duration, 
with breast, prostate, colorectal and lung cancer incidence within Alberta`s Tomorrow Project 
(ATP) cohort. This study also assessed whether sleep duration is an effect modifier of the 




The methods for ATP Phase I have been previously described [10]. Ethical approval was 
obtained from the Health Research Ethics Board of Alberta–Cancer Committee (HREBA.CC-16-
0495) and written informed consent was obtained from participants. Surveys 2004 and 2008 
from Phase I of ATP collected information on rotating and night shift work employment and 
sleep duration. Participants were asked: “For how many years did you work a schedule that 
included day or evening work that rotated with nights in the same month?” and “For how many 
years did you work straight night shifts?” Participants who completed Survey 2004 were also 
asked: “On average, how many hours did you sleep each night during the past 4 weeks?”, 
whereas participants who completed Survey 2008 were asked: “On average over the past 7 days, 
at what time did you normally go to sleep?” and “On average over the past 7 days, at what time 
did you normally wake up?” This information was used to estimate sleep duration. 
 
Data on primary incident cancers were obtained through linkage with the Alberta Cancer 
Registry (ACR) in August 2018. Incident cases of breast, prostate, colorectal and lung cancers 
were included in these analyses based on scientific plausibility [1,2,3,4,5,11,12] and the number 
of cancer cases exceeding 100 cases/site. Covariates of interest included: age (years), sex 
(male/female), body mass index (<25 kg/m2/≥25 kg/m2), highest level of education (high school 
or less/some post-high school education or a post-high school certificate or degree), total 
household income ($0 to $49,999/$50,000 to $99,999/≥$100,000), employment status (yes/no), 
ethnicity (Caucasian/Other), marital status (married or living with someone/divorced, separated, 
or widowed/single, never married), smoking status (daily/occasional/former/never), presence of 
at least one medical condition/co-morbidity (e.g. diabetes, depression) (yes/no), and having a 
family history of cancer (yes/no). A proxy for menopausal status (<55 years of age/≥55 years of 
age) was included in the breast cancer incidence analysis. Follow-up time was determined as the 
elapsed time between the date of questionnaire completion and the date of cancer diagnosis or 
linkage with the ACR in August 2018, whichever came first. 
 
Baseline characteristics were examined as means ± standard deviations for continuous variables 
or as counts and percentages for categorical variables. Differences in covariate characteristics 
between cancer and non-cancer cases were assessed using ANOVA for continuous variables and 
chi-square tests for categorical variables. Cox proportional hazard regression models estimated 
multivariable-adjusted hazards ratios (HR) and 95 % confidence intervals (95 % CIs) between 
years of rotating shift work employment (never having worked shifts as the referent group versus 
0.1−5.9 years of shift work and ≥6 years of shift work) and having ever (versus never as the 
referent group) worked night shifts with breast, prostate, colorectal and lung cancer incidence. 
We dichotomized night shift work as ever/never because <10 cases per cancer site investigated 
reported ≥6 years of shift work experience. Cox proportional hazard regression models were also 
used to estimate multivariable-adjusted HRs and 95 % Cis between sleep duration categories 
(7−9 h of sleep/day as the referent group versus <7 h of sleep/day and >9 h of sleep/day) with 
cancer incidence. We repeated all risk analyses after excluding cancer cases that were diagnosed 
within two years of questionnaire completion to address the potential issue of a short latency 
period between exposure measurement and cancer incidence. For our second aim, we examined 
whether sleep duration is an effect modifier of the association between shift work and cancer 
incidence by adding a sleep duration-rotating/continuous night shift work interaction term to the 
multivariable-adjusted models. Stratified analyses were conducted if the interaction term 
reached P < 0.10. All statistical analyses were performed using STATA v14 (College Station, 




Descriptive results are presented in Table 1. Cancer cases were older, more likely to be 
unemployed, have a lower total household income and a family history of cancer. A greater 
proportion of lung cancer cases and non-prostate cancer cases reported longer night shift work 
employment. 
 
Results on the associations between shift work and sleep duration with cancer incidence are 
presented in Table 2. Having worked ≥6 years of rotating shift work was associated with an 
increased risk of lung cancer in the multivariable-adjusted model. Having ever worked night 
shifts was also associated with an increased risk of lung cancer in the multivariable- and latency-
multivariable-adjusted models, whereas having ever worked night shifts was associated with a 
reduced risk of prostate cancer in the latency-adjusted model only. No associations were found 
between shift work or sleep duration on the risks of breast and colorectal cancer. The rotating 
shift work-sleep duration interaction term was borderline significant (P = 0.06) when added to 
the multivariable-adjusted models. Stratified analyses revealed borderline increased risk of lung 
cancer in participants with ≥6 years of rotating shift work and <7 h of sleep/day, and an 
increased risk of lung cancer in participants with 0.1−5.9 years of rotating shift work and >9 h of 
sleep/day (Table 3). There was no evidence of an increased risk of lung cancer according to 
rotating shift work categories in participants with 7−9 h of sleep/night (Table 3). There was also 
no additional evidence of effect modification by sleep duration for rotating and night shift work 
with breast, prostate and colorectal cancer incidence, nor night shift work with lung cancer 
incidence (all P-values >0.10). Therefore, no additional stratified analyses were conducted. 
 
Table 1. Descriptive statistics for Alberta’s Tomorrow Project study participants who have data on rotating and night shift work 
employment and consented to data linkage, n = 21,804, 2001-2018.  
























Cancer Cases P-value* 
n = 366 n = 13,091  n = 321 n = 8,026  n = 152 n = 21,652  n = 162 n = 21,642  
Age (years) 56.7 (9.1) 53.6 (9.2) <0.0001 59.3 (7.3) 53.6 (9.0) <0.0001 59.6 (8.5) 53.7 (9.1) <0.0001 62.5 (6.7) 53.7 (9.1) <0.0001 
Sex 
            
Male NA NA NA NA NA NA 72 (47.4) 8,275 (38.2) 0.07 55 (34.0) 8,292 (38.3) 0.37 
Female NA NA NA NA NA NA 80 (52.6) 13,377 (61.8) 0.16 107 (66.1) 13,350 (61.7) 0.48 
Body mass index 
            
<25 kg/m2 142 (38.8) 5,231 (40.0) 0.95 66 (20.6) 1,793 (22.3) 0.82 29 (19.1) 7,203 (33.3) 0.01 59 (36.4) 7,173 (33.1) 0.78 
≥25 kg/m2 221 (60.4) 7,660 (58.5) 0.90 253 (78.8) 6,173 (76.9) 0.95 121 (79.6) 14,186 (65.5) 0.10 101 (62.4) 14,206 (65.6) 0.86 
Missing 3 (0.8) 200 (1.5) 0.55 2 (0.6) 60 (0.8) 0.95 2 (1.3) 263 (1.2) 1.00 2 (1.2) 263 (1.2) 1.00 
Ethnicity 
            
Caucasian 334 (91.3) 12,049 (92.0) 1.00 300 (93.5) 7,363 (91.7) 0.95 141 (92.8) 19,905 (91.9) 1.00 150 (92.6%) 19,896 (91.9) 1.00 
Other 30 (8.2) 995 (7.6) 0.90 19 (5.9) 627 (7.8) 0.50 11 (7.2) 1,660 (7.7) 1.00 12 (7.4) 1,659 (7.7) 1.00 
Missing 2 (0.6) 47 (0.4) 0.86 2 (0.6) 36 (0.5) 0.90 0 (0) 87 (0.4) 0.74 0 (0) 87 (0.4) 0.70 
Marital Status 
            
Married or living with someone 271 (74.0) 9,981 (76.2) 0.98 275 (85.7) 6,706 (83.6) 0.98 118 (77.6) 17,115 (79.1) 1.00 117 (72.2) 17,116 (79.1) 0.80 
Divorced, separated or 
widowed 
67 (18.3) 2,484 (19.0) 0.99 31 (9.7) 836 (10.4) 0.98 27 (17.8) 3,391 (15.7) 0.94 44 (27.2) 3,374 (15.6) 0.003 
Single, never married 28 (7.7) 617 (4.7) 0.09 15 (4.7) 479 (6.0) 0.83 7 (4.6) 1,132 (5.2) 0.99 1 (0.6) 1,138 (5.3) 0.09 
Missing 0 (0) 9 (0.1) 0.96 0 (0) 5 (0.1) 0.98 0 (0) 14 (0.1) 0.99 0 (0) 14 (0.1) 0.99 
Education 
            
High school or less 119 (32.5) 3,776 (28.8) 0.43 87 (27.1) 1,993 (24.8) 0.74 52 (34.2) 5,923 (27.4) 0.27 71 (43.8) 5,904 (27.3) 0.0003 
Some post-high school 
education or a post-high 
school degree or certificate 
247 (67.5) 9,307 (71.1) 0.70 233 (72.6) 6,027 (75.1) 0.86 100 (65.8) 15,714 (72.6) 0.61 91 (56.2) 15,723 (72.7) 0.05 
Missing 0 (0) 8 (0.1) 0.90 1 (0.3) 6 (0.1) 0.35 0 (0) 15 (0.1) 0.95 0 (0) 15 (0.1) 0.95 
Total household income 
            
$0 - $49,999 125 (34.2) 4,044 (30.9) 0.75 84 (26.2) 1,640 (20.4) 0.18 65 (42.8) 5,828 (26.9) 0.003 83 (51.2) 5,810 (26.9) <0.0001 
$50,000 - $99,999 132 (36.1) 4,573 (34.9) 0.99 134 (41.7) 3,171 (39.5) 0.94 54 (35.5) 7,956 (36.7) 0.99 53 (32.7) 7,957 (36.8) 0.87 
≥$100,000 78 (21.3) 3,662 (28.0) 0.13 84 (26.2) 2,931 (36.5) 0.03 27 (17.8) 6,728 (31.1) 0.04 18 (11.1) 6,737 (31.1) 0.0001 
Missing 31 (8.5) 812 (6.2) 0.41 19 (5.9) 284 (3.5) 0.19 6 (4.0) 1,140 (5.3) 0.92 8 (4.9) 1,138 (5.3) 1.00 
 
























Cancer Cases P-value* 
n = 366 n = 13,091  n = 321 n = 8,026  n = 152 n = 21,652  n = 162 n = 21,642  
Employment status 
        
Yes 211 (57.7) 8,442 (64.5) 0.27 223 (69.5) 6,425 (80.1) 0.12 80 (52.6) 15,221 (70.3) 0.04 66 (40.7) 15,235 (70.4) 0.00004 
No 155 (42.4) 4,640 (35.4) 0.09 98 (30.5) 1,594 (19.9) 0.0002 72 (47.4) 6,415 (29.6) 0.0003 96 (59.3) 6,391 (29.5) <0.0001 
Missing 0 (0) 9 (0.1) 0.86 0 (0) 7 (0.1) 0.86 0 (0) 16 (0.1) 0.95 0 (0) 16 (0.1) 0.95 
Smoking status 
            
Never 235 (64.2) 8,162 (62.4) 0.99 219 (68.2) 4,831 (60.2) 0.51 91 (59.9) 13,356 (61.7) 0.99 39 (24.1) 13,408 (62.0) <0.0001 
Former 76 (20.8) 3,034 (23.2) 0.92 69 (21.5) 1,915 (23.9) 0.95 34 (22.4) 5,060 (23.4) 0.99 39 (24.1) 5,055 (23.4) 1.00 
Occasional 7 (1.9) 317 (2.4) 0.98 8 (2.5) 249 (3.1) 0.98 3 (2.0) 578 (2.7) 0.99 6 (3.7) 575 (2.7) 0.95 
Daily 47 (12.8) 1,559 (11.9) 0.99 25 (7.8) 1,022 (12.7) 0.20 24 (15.8) 2,629 (12.1) 0.79 78 (48.2) 2,575 (11.9) <0.0001 
Missing 1 (0.3) 19 (0.2) 0.98 0 (0) 9 (0.1) 0.98 0 (0) 29 (0.1) 0.99 0 (0) 29 (0.1) 0.99 
Presence of at least 1 medical 
condition or co-morbidity 
            
No 80 (21.9) 3,647 (27.9) 0.10 92 (28.7) 2,890 (36.0) 0.10 34 (22.4) 6,675 (30.8) 0.17 20 (12.4) 6,689 (30.9) 0.0001 
Yes 286 (78.1) 9,426 (72.0) 0.39 228 (71.0) 5,118 (63.8) 0.29 118 (77.6) 14,940 (69.0) 0.45 141 (87.0) 14,917 (68.9) 0.02 
Missing 0 (0) 18 (0.1) 0.78 1 (0.3) 18 (0.2) 0.95 0 (0) 37 (0.2) 0.86 1 (0.6) 36 (0.2) 0.39 
Family history of cancer 
            
No 150 (41.0) 5,864 (44.8) 0.27 124 (38.6) 3,956 (49.3) 0.01 52 (34.2) 10,042 (46.4) 0.03 62 (38.3) 10,032 (46.4) 0.13 
Yes 216 (59.0) 7,227 (55.2) 0.34 197 (61.4) 4,070 (50.7) 0.01 100 (65.8) 11,610 (53.6) 0.04 100 (61.7) 11,610 (53.7) 0.16 
Follow-up time (years) 5.5 (3.5) 11.0 (2.5) <0.0001 5.8 (3.5) 11.0 (2.6) <0.0001 5.8 (3.2) 10.9 (2.7) <0.0001 6.0 (3.6) 10.9 (2.7) <0.0001 
Rotating shift work 
employment category 
            
Having never worked rotating 
shifts 
258 (70.3) 9,087 (69.4) 1.00 165 (51.4) 3,691 (46.0) 0.37 84 (55.3) 13,117 (60.6) 0.70 91 (56.2) 13,110 (60.6) 0.78 
0.1-5.9 years 64 (17.4) 2,493 (19.0) 0.78 89 (27.7) 2,528 (31.5) 0.50 40 (26.3) 5,134 (23.7) 0.82 35 (21.6) 5,139 (23.7) 0.86 
≥6 years 45 (12.3) 1,512 (11.6) 0.70 67 (20.9) 1,812 (22.6) 0.82 28 (18.4) 3,408 (15.7) 0.70 36 (22.2) 3,400 (15.7) 0.12 
Night shift work employment 
category 
            
Having never worked night 
shifts 
324 (88.5) 11,449 (87.4) 1.00 267 (83.2) 6,166 (76.8) 0.21 125 (82.2) 18,081 (83.5) 1.00 124 (76.5) 18,082 (83.5) 0.34 
Having ever worked night shifts 42 (11.5) 1,645 (12.6) 0.58 54 (16.8) 1,866 (23.2) 0.02 27 (17.8) 3,580 (16.5) 0.75 38 (23.5) 3,569 (16.5) 0.03 
Sleep duration category 
            
<7 h/day 64 (17.5) 1,921 (14.7) 0.37 63 (19.6) 1,600 (19.9) 1.00 27 (17.8) 3,621 (16.7) 0.95 30 (18.3) 3,618 (16.7) 0.90 
 
























Cancer Cases P-value* 
n = 366 n = 13,091  n = 321 n = 8,026  n = 152 n = 21,652  n = 162 n = 21,642  
7−9 h/day 267 (73.2) 9,864 (75.3) 0.90 236 (73.3) 5,981 (74.2) 1.00 115 (75.6) 16,233 (74.8) 1.00 113 (68.9) 16,235 (74.9) 0.67 
>9 h/day 34 (9.3) 1,313 (10.0) 0.90 23 (7.1) 473 (5.9) 0.67 10 (6.6) 1,833 (8.5) 0.74 21 (12.8) 1,822 (8.4) 0.16 
NA, Not applicable. 
* P-values for the differences in descriptive data between all cancer cases and all non-cancer cases. 
§ Analyses for breast and prostate cancer incidence are limited to female and male participants, respectively. One male breast cancer case was excluded from 
these analyses because there was not sufficient statistical power to run these analyses by sex, or adjust for sex as a covariate. 
 
Table 2. Cox regression hazard ratios for rotating and night shift work employment, and sleep duration, with breast, prostate, 
colorectal and lung cancer incidence. 
Years of rotating shift work employment Cases Multivariable-adjusted HR (95 % CI)1 P value Cases Latency multivariable-adjusted HR (95 % CI)2 P value 
Breast cancer       
Having never worked rotating shifts 258 1.00 (Referent group)  213 1.00 (Referent group)  
0.1−5.9 years of rotating shift work 64 0.92 (0.70, 1.21) 0.57 51 0.89 (0.65, 1.21) 0.45 
≥6 years of rotating shift work 45 1.02 (0.74, 1.41) 0.89 34 0.94 (0.65, 1.36) 0.75 
Prostate cancer       
Having never worked rotating shifts 165 1.00 (Referent group)  140 1.00 (Referent group)  
0.1−5.9 years of rotating shift work 89 0.86 (0.66, 1.12) 0.26 74 0.84 (0.63, 1.11) 0.22 
≥6 years of rotating shift work 67 0.88 (0.66, 1.17) 0.36 55 0.84 (0.61, 1.15) 0.28 
Colorectal cancer       
Having never worked rotating shifts 84 1.00 (Referent group)  73 1.00 (Referent group)  
0.1−5.9 years of rotating shift work 40 1.21 (0.82, 1.78) 0.33 33 1.15 (0.75, 1.74) 0.53 
≥6 years of rotating shift work 28 1.15 (0.74, 1.79) 0.53 23 1.10 (0.68, 1.77) 0.71 
Lung cancer       
Having never worked rotating shifts 91 (Referent group)  79 1.00 (Referent group)  
0.1−5.9 years of rotating shift work 35 1.17 (0.79, 1.74) 0.44 30 1.16 (0.75, 1.78) 0.50 
≥6 years of rotating shift work 36 1.59 (1.07, 2.37) 0.02 29 1.48 (0.96, 2.30) 0.08 
Ever versus never night shift work employment Cases Multivariable-adjusted HR (95 % CI)1 P value Cases Latency multivariable-adjusted HR (95 % CI)2 P value 
Breast cancer       
Having never worked night shifts 324 1.00 (Referent group) a 263 1.00 (Referent group)  
Having ever worked night shifts 42 0.88 (0.64, 1.23) 0.44 34 0.87 (0.61, 1.25) 0.47 
Prostate cancer       
Ever versus never night shift work employment Cases Multivariable-adjusted HR (95 % CI)1 P value Cases Latency multivariable-adjusted HR (95 % CI)2 P value 
Having never worked night shifts 267 1.00 (Referent group)  226 1.00 (Referent group)  
Having ever worked night shifts 54 0.76 (0.57, 1.02) 0.07 43 0.70 (0.51, 0.98) 0.04 
Colorectal cancer       
Having never worked night shifts 125 1.00 (Referent group)  106 1.00 (Referent group)  
Having ever worked night shifts 27 1.07 (0.70, 1.63) 0.77 23 1.08 (0.68, 1.71) 0.74 
Lung cancer       
Having never worked night shifts 124 1.00 (Referent group)  105 1.00 (Referent group)  
Having ever worked night shifts 38 1.71 (1.18, 2.47) 0.01 33 1.76 (1.18, 2.62) 0.01 
Sleep duration Cases Multivariable-adjusted HR (95 % CI)1 P value Cases Latency multivariable-adjusted HR (95 % CI)2 P value 
Breast cancer       
7−9 h/day 267 1.00 (Referent group) a 216 1.00 (Referent group)  
<7 h/day 64 1.06 (0.80, 1.39) 0.69 55 1.10 (0.81, 1.48) 0.55 
>9 h/day 34 1.01 (0.70, 1.45) 0.96 25 0.96 (0.63, 1.47) 0.86 
Prostate cancer       
7−9 h/day 236 1.00 (Referent group)  199 1.00 (Referent group)  
<7 h/day 63 1.04 (0.78, 1.37) 0.81 54 1.04 (0.76, 1.40) 0.82 
>9 h/day 23 1.30 (0.84, 2.02) 0.23 18 1.23 (0.75, 2.01) 0.41 
Colorectal cancer       
7−9 h/day 115 1.00 (Referent group)  98 1.00 (Referent group)  
<7 h/day 27 0.97 (0.63, 1.48) 0.88 23 0.97 (0.61, 1.53) 0.88 
>9 h/day 10 0.76 (0.39, 1.46) 0.41 8 0.72 (0.34, 1.49) 0.37 
Lung cancer       
7−9 h/day 113 1.00 (Referent group)  97 1.00 (Referent group)  
<7 h/day 30 1.14 (0.76, 1.71) 0.53 25 1.08 (0.69, 1.69) 0.73 
>9 h/day 21 1.40 (0.87, 2.26) 0.16 18 1.42 (0.85, 2.38) 0.19 
1 Adjusted for: age, sex (colorectal and lung cancers), body mass index (BMI), highest level of education, total household income, employment status, ethnicity, 
marital status, smoking status, presence of at least one medical condition/co-morbidity, family history of cancer, menopausal status (breast cancer only). 
2 Cancers occurring <2 years after questionnaire completion were removed. 
 
  
Table 3. Stratified results by sleep duration for the association between rotating shift work employment with lung cancer incidence. 
Stratified analyses - 7−9 h of sleep/day Cases Multivariable-adjusted HR (95 % CI) P value 
Having never worked rotating shifts 69 1.00 (Referent group)  
0.1−5.9 years of rotating shift work 20 0.91 (0.55, 1.52) 0.73 
≥6 years of rotating shift work 22 1.38 (0.84, 2.26) 0.20 
Stratified analyses - <7 h of sleep/day Cases Multivariable-adjusted HR (95 % CI) P value 
Having never worked rotating shifts 20 1.00 (Referent group)  
0.1−5.9 years of rotating shift work 7 1.39 (0.54, 3.58) 0.49 
≥6 years of rotating shift work 8 2.27 (0.95, 5.41) 0.07 
Stratified analyses - >9 h of sleep/day Cases Multivariable-adjusted HR (95 % CI) P value 
Having never worked rotating shifts 22 1.00 (Referent group)  
0.1−5.9 years of rotating shift work 10 2.99 (1.12, 7.97) 0.03 
≥6 years of rotating shift work 4 1.79 (0.54, 5.96) 0.35 
1Adjusted for: age, sex, body mass index (BMI), highest level of education, total household income, employment status, ethnicity, marital status, smoking status, 




In this subsample of the ATP cohort, we found that having worked ≥6 years of rotating shift 
work and having ever worked night shifts were associated with an increased risk of lung cancer, 
whereas having ever worked night shifts was associated with a reduced risk of prostate cancer in 
the latency-adjusted model only. No evidence of a main effect of sleep duration on cancer 
incidence was noted. There was some evidence of effect modification by sleep duration for the 
rotating shift work-lung cancer incidence association in this sample, with stratified results 
suggesting an increased risk of lung cancer in individuals with <7 h and >9 h of sleep/day, but no 
evidence of an increased risk of lung cancer with rotating shift work exposure in individuals with 
7−9 h of sleep/day. 
 
There is some strong and consistent evidence that longer exposures to shift work are associated 
with cancer incidence, especially with breast and prostate cancers. Three major studies found 
statistically significant associations between >5 years of shift work exposure and breast cancer 
incidence [3,13,14]. An increased risk of prostate cancer was found in three of the most recent 
meta-analyses [1,2,15], with another recent study noting linear increases in prostate cancer risk 
with length of rotating or night shift work [16]. Finally, associations between shift work length 
with colorectal and lung cancers have been inconsistent to date. One study reported that 
increasing lifetime exposure to rotating shift work was associated with an increased risk of 
colorectal cancer [6], and another reported an increased risk of lung cancer with ≥15 years of 
shift work in smokers only [7]. Conversely, no evidence of a shift work-cancer risk association 
for both colorectal and lung cancer incidence were noted in a sample of Canadian men [5]. 
 
We observed some evidence of an increased risk of lung cancer with rotating shift work 
exposure in participants with both shorter and longer sleep durations, which was not present in 
participants reporting 7−9 h of sleep/day. These results partially corroborate findings from two 
studies conducted in China that have reported greater combined cancer risk in retired male night 
shift workers [8], and greater breast cancer risk in females having ever worked night shifts who 
also reported short (≤6 h/day) and long (≥9 h/day) sleep durations [9]. Biologic mechanisms 
hypothesized to predispose shift workers to shorter sleep durations and an increased risk of 
cancer include reductions in glucose tolerance, the upregulation of appetite, and increased 
inflammation [17]. Shift workers may also have poorer lifestyle choices due to work schedules, 
which may include tobacco use, greater unhealthy food consumption, and lower physical activity 
participation [17]. Conversely, long sleep duration can often be confounded by the presence of 
comorbidities and/or poorer sleep quality [18], which may also increase the risk of cancer. 
 
Strengths of these analyses include the availability of information on a large number of 
covariates, the use of prospectively-collected data, and the identification of cancer cases through 
registry linkage. Limitations include the measurement of self-reported shift work and sleep 
duration with questionnaires which may lead to exposure misclassification, no information 
collected on job/industry work to complement shift work employment data, and the low 
proportion of participants who reported ≥6 years of night shift work employment and <7 or >9 h 
of sleep/night. 
 
Our findings provide preliminary evidence of an association between shift work employment and 
increased lung cancer risk in a Canadian sample. Furthermore, some evidence of an increased 
risk of lung cancer with rotating shift work exposure in participants with both shorter and longer 
sleep durations was noted. Additional studies are needed to confirm our results. Studies using 
objective sleep measurements are also needed to complement these findings. 
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